Resumen de New MS drug approved

Diane S. Aschenbrenner

• * Teriflunomide (Aubagio) has been approved to treat adults with relapsing multiple sclerosis.

  * The drug label carries boxed warnings that teriflunomide can produce hepatotoxicity and that its use during pregnancy can cause birth defects.